A WORLD-CLASS LINE-UP

Gurmeet Singh is a senior director, Business Development at West. In her current role, she manages a global team that collaborates with strategic pharmaceutical companies to sell services and solutions to support the development of combination products to bring optimal drug delivery options for patients, caregivers and providers. These include West proprietary product platforms and third party drug delivery solutions, with services that include design and development through clinical readiness to scale-up and manufacturing. Gurmeet is an experienced business leader in pharmaceutical packaging, including drug delivery devices, for injectable drugs with a strong focus in combination product development and commercialization projects working with multiple global pharmaceutical partners. She is passionate about bringing innovative solutions that are designed with the patient in mind, with the intent to improve their lives. Gurmeet is knowledgeable and experienced professional supporting all aspects of device development, cGMP manufacturing as well as global regulatory compliance.

Gemma Budd is Business Development Director for Nanopharm, an Aptar Company, where she is primarily responsible for developing business and collaborative opportunities for Aptar Pharma’s services, solutions and technologies in the orally inhaled and nasal drug product (OINDP) sector. With a university degree in Biomedical Sciences, Gemma has over 10 years of experience in the pharmaceutical industry in both research and commercial positions, from materials science and analytical services, to formulation technology and drug delivery devices, primarily for oral and inhaled dosage forms. 

Dr. Mahler is Founder, CEO and Board Member at ten23 health AG, the human-centric and sustainable pharmaceutical development partner.
He is also adjunct faculty at the Universities of Frankfurt (Germany) and Basel (Switzerland), serves as Scientifc Expert (Ph.Eur.) at EDQM and as Board Member for Bionter & KriyaBio.
Previously, Dr. Mahler has been leading the Drug Product Services Business Unit at Lonza AG, leading Pharmaceutical Development & Supplies Biologics at Roche (Basel), and as Principal Scientist & CMC Team leader Erbitux at Merck KGaA. 
He studied Pharmacy & holds in Ph.D. in Toxicology from the University of Mainz.

Hugo Alexandre Ferreira holds degrees in medicine and in engineering physics and has a PhD in physics on the topic of bionanotechnology. He then worked in the medical device industry prior to returning to academia. Currently, he is an associate professor of biomedical engineering and biophysics at the University of Lisbon, teaching medical devices and digital health, and a PI in the fields of exponential digital technologies applied to health, including AI, XR, 3D printing, BCIs, wearables, and blockchain. Finally, he has co-founded and managed companies in the fields of IVD and imaging diagnostics, digital health, and sports and serves as a consultant and advisor in those fields.

Mr. Hiroki Hasegawa is a researcher of research laboratory. He gained a Diploma in Science in 2013 and a Master Degree of Science in 2015 from Osaka University.Since April 2015 he has been working for Mitsubishi Gas Chemical Company, Inc. and in charge of macromolecular science, especially in composition development of thermosetting resin.Since 2018 he has joined a development team of multilayer plastic vial & syringe for biologics.

Julien Storz is Director of Business Development within Aptar Pharma’s Consumer Healthcare (CHC) division. He holds a bachelor’s degree in Business Administration and has over 19 years of medical industry experience. Julien joined Aptar Pharma and the CHC Global Market Development team in 2019, where he is responsible for supporting business development efforts across numerous application fields in addition to driving CHC sustainability efforts.Join Julien Storz’ Learning Lab presentation to learn more and get introduced to the first in market metal-free recyclable nasal spray pump.

Juergen combines the medical, business and packaging world in his vita. With a bachelor’s degree in International Business Administration and an Executive MBA in Sales & Marketing Management, Jürgen spent the first 20 years of his professional life in different leadership roles in Amcor. Being also an advanced paramedic, he is passionate about the healthcare world and can add first-hand experience as a user to the sterile barrier world. Since 2018, Juergen is with Suedpack Medica and develops with his team the business of the future.

Iain is a Commercial Director at Phillips-Medisize, where he is part of a global team developing industry leading solutions and platforms for drug delivery, digital medicine and connected health.He has worked for more than 20 years principally in lifesciences with an increasing focus on the use of devices and digital technologies to support drug deliveryHe has a degree and PhD in physics both from University College London and an MBE in Technology Management from the Open University. He lectures on Bioscience Enterprise at the University of Cambridge and is a regular conference speaker

Keith Dodson is Vice President of Global Business Development and leads AST's global sales team. With an engineering background, Keith brings over 26 years total experience in the pharmaceutical and CDMO space having worked for multinational companies including 3M, Thermo Fisher, Eurofins and Catalent. Over his career, Keith has helped his customers around the world to identify, scope, and successfully implement capital equipment and technical services projects addressing critical business needs.

Kristien De Clercq is an experienced mechanical engineer with over nine years’ experience as a consultant in medical device development. She has led and delivered projects in a wide range of medical fields including specialist applications for ophthalmology and vascular conditions. Kristien draws on her background in aerodynamics and biomechanics, to bring creative ideas to her designs. As project leader at Springboard, she has a proven record of delivering technical excellence. She studied for a BSc in Aeronautical Engineering and a MSc in Experimental Aerodynamics at Delft University of Technology, followed by a postgraduate in Zoology at Cambridge University.

Lionel Jeannin is an Arts & Métiers ParisTech Engineer with a Master's degree in Business Administration from IAE Aix-Marseille Graduate School of Management. He earned certificates in Biochemistry and Biology, respectively, from Harvard University and the Massachusetts Institute of Technology. He has more than 22 years of experience in the Medical Device and Pharmaceutical industry. 
He has worked as a Project and Development Team Manager in the Industrial Engineering, Ophthalmic surgery Medical Devices, Parenteral Nutrition and OTC/Rx Pharmaceutical development domains. He is currently heading the Oral Packaging and Delivery Systems Group in the Global Device and Packaging Development department of Novartis Pharma Technical Research and Development division.

Lionel is Associate Director at BD responsible for Program Management of New Product development and Sustaining Engineering activities. Lionel joined BD in 2005 and held roles of increasing responsibilities within the R&D and Project Management Office. 
He has a deep experience in Drug Delivery Systems Design and Development from the Innovation stage to commercialisation in the field of Prefillable Syringes, Autoinjectors, Safety systems and Pens. 
He developed, in particular, BD Physioject™ Autoinjector, which is listed in many patents. Before BD, Lionel worked in the Automotive Industry. He has a Master’s Degree in Engineering, specialising in plastic parts design and manufacturing.

Mario is an experienced pharmaceutical development professional with over 30 years of CMC contributions to pharmaceutical companies in international environment (Italy, Germany, Switzerland).
He has extensive experience in formulation and process development of Drug Products for clinical supplies, tech transfer and commercial manufacturing, including successful FDA approval of Mavenclad® for multiple sclerosis and Xadago® for Parkinson’s disease. Moreover, he contributed to the invention of a drug delivery system based on mesoporous silica for oral bioavailability enhancement (Parteck® SLC).
Currently he works as freelance CMC consultant, offering high added-value consultancy for Interim Management, CDMO/CMO outsourcing, IND/IMPD writing, EMA/FDA Scientific Advice meetings, due diligences and licensing.
Mario holds a MSc in Pharmacy and a MSc in Pharmaceutical Chemistry and Technology from University of Turin, Italy, and advanced Pharma Management education from London Business School, UK and Columbia Business School, NYC, USA.

With a Bachelor’s degree in process engineering / mechanical engineering and Master's degree in plastics engineering, Michael is a technology lover and passionate about plastics!  He has more than 25 years’ experience in packaging, and over 15 years in packaging for pharmaceuticals and GMP environment.  Since early 2020 Michael works with SÜDPACK Medica as Head of R&D.  He formerly worked with Etimex Primary Pack as Head of Development.  Michael held various roles with BP in production and development, including application engineering, where he supported machine builders and customers during FAT & SAT, including troubleshooting. Michael was also Head of Sales with responsibility for CPP (Cast Polypropylene).

Started at Südpack Medica in September 2021.  With a dual Bachelor’s degree in Industrial Design and Mechanical Engineering, Pieter brings over 16 years of experience in healthcare packaging with expertise in rigid barrier packaging.  Focused on including patient safety till the point of care and improving patient outcomes.Formerly worked at Nelipak Healthcare Packaging with multiple international leadership roles in packaging design, development, and innovation management. Active member in Kilmer innovations in Packaging Sustainability committee, education committee, and the Sterile Barrier Association.

Roberto Valenti is Head of Materials Development in Bormioli Pharma. After a first experience as technical for quality control of the raw materials, he has been in charge since January 1999 of the R&D activities aimed at the use and validation of innovative materials, such as sustainable plastics (recycled, bio-based) or barrier materials. Roberto Valenti is constantly updated on the latest developments through a consolidated network of partners and suppliers, supporting clients on their materials innovation projects.

Richard holds a bachelor’s engineering degree with honours in product design for manufacture. Richard started his career as an R&D engineer in 1995 designing inhalation drug delivery devices. He then went on to design combination/medicinal products at Bespak and later transitioned to Covidien (Medtronic) where he held roles in international upstream marketing and business development. He then moved on to various roles at Owen Mumford, Bespak and Novo Nordisk Engineering (NNE) in Denmark, before re-joining Owen Mumford in 2016. Richard is now dedicated to managing new injectable platform devices for Pharma and Biotech companies that meet market and user needs.

Tom is a senior industrial design consultant at Team Consulting, where he promotes effective design through clear and creative design decisions. He has over twelve years’ experience in design consulting and has been the lead industrial designer on several projects ranging from medical devices to consumer electronics. He has a degree in Industrial Design Technology from Brunel University London.

Tom leads engineering and scientific teams developing new injection devices, pumps and inhalers. He has been the named inventor on dozens of patents throughout his 20 years’ experience in industry.He is a regular speaker at various international conferences on innovation and medical device development, and mentors Engineering and MBA students at the Cambridge University Engineering Department and the Judge Business School.He read Engineering at Cambridge University before becoming the Choate Fellow in Human Physiology and Pathology at Harvard University.

Tom Van Ginneken studied chemical engineering in Antwerp and added a MBA from the university of Sankt Gallen to his resume. After working in the chemical and pharmaceutical sector in Belgium for 3 years he joined SCHOTT in 2008.After different positions in the pharmaceutical product development department he became part of the product management team with focus on the SCHOTT TOPPAC® brand. In this role he works on the strategic orientation and innovation pipeline of the product group.

I’ve been in the pharmaceutical industry for almost 9 years developing medical devices end to end, primarily in the combination product space. I’ve worked in all phases of development and excel at strategizing organizational development, platforms, and pipelines. Understanding stakeholder needs, the true context of use, and presenting unique solutions are some of my strong suits. With my broad range of product and patient experience, I bring a unique perspective.